SpringWorks Therapeutics, Inc. Annual Operating Income (Loss) in USD from 2018 to 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
SpringWorks Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2018 to 2024.
  • SpringWorks Therapeutics, Inc. Operating Income (Loss) for the quarter ending December 31, 2024 was -$81.3M, a 17.4% increase year-over-year.
  • SpringWorks Therapeutics, Inc. Operating Income (Loss) for the twelve months ending December 31, 2024 was -$278M, a 18.9% increase year-over-year.
  • SpringWorks Therapeutics, Inc. annual Operating Income (Loss) for 2024 was -$278M, a 18.9% increase from 2023.
  • SpringWorks Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$343M, a 22.2% decline from 2022.
  • SpringWorks Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$281M, a 61.8% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$278M +$64.9M +18.9% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-20
2023 -$343M -$62.3M -22.2% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-20
2022 -$281M -$107M -61.8% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-20
2021 -$173M -$127M -274% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-27
2020 -$46.3M +$12.9M +21.8% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 -$59.2M -$40.7M -220% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
2018 -$18.5M Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.